Hemeteam has six parts.

1: Common problems
2: Case Studies
3: Hematopoiesis
4: Diseases of blood formation
5: Bleeding and clotting
6: Targeted therapy

Welcome to HemeTeam 2010

HemeTeam is a companion to hematological studies. It focuses on the basic concepts: pathophysiology, diagnosis and treatment. It is designed to facilitate self-directed learning of the basics, and keeping current. Chapters are frequently updated.

To Navigate:

Click on the chapters listed below.
Use navigation buttons and hotwords to access the information you want.
Use your browser's back (or forward) arrow to come back to this page.

Contents

Part 1. Common problems

• Diagnosis of anemia
• Anemia of chronic disease
• Blood and marrow smears
• Abnormal leukocyte counts
• Approach to abnormal platelet counts
• Lymphadenopathy
• approach  to splenomegaly
• Bleeding
• Venous thromboembolism (VTE)
• Acute leukemia (an introduction) 

back to top

Part 2. Case studies

• microcytic anemia in a marathon runner
• anemia in a patient with a chronic disease (ACD)
• anemia in a greek woman
• unexplained macrocytosis
• fatigue and bruising in an auto mechanic
• pancytopenia post influenza
• ALL in a male aged 3 in 1966
• AML: 5 case studies
• APL in a Jehovah's witness
• Thymic mass in an infant
• Hodgkin's disease in a young boy
• Peripheral T - cell lymphoma- 5 cases
• Vignettes- complications of polycythemia vera
• Polycythemia and ascites
• Splenomegaly in a 76 year old lawyer

back to top

Part 3. Hematopoiesis

• Overview of Hematopoiesis
• cell cycle 
• stem cells
• telomerase
• apoptosis
• angiogenesis
• endothelium
• granulopoiesis
• thrombopoiesis
• lymphopoiesis
• aplastic anemia  and pancytopenia

back to top

Part 4. Diseases of Blood Formation:

a) Erythrocytes

• Diagnosis of different types of anemia
• microcytic
• macrocytic
• normocytic
• hemolytic
• anemia of chronic disease
• sickle cell disease
• iron deficiency, absorption, transport etc
• hemochromatosis

b) Stem cells

• acute myelogenous leukemia (AML)
• acute promyelocytic leukemia (APL)
• prognostic factors in AML
• biology of acute myeloid leukemia (AML)
• minimal residual disease (MRD)
• multidrug resistance (MDR)
• stem cell transplantation (SCT) in AML
• chronic myelogenous leukemia (CML)
• biology of CML
• inatinib mesylate (targeted Rx for CML
• myeloproliferative disorders (MPD)
• polycythemia rubra vera (PRV)
• essential thrombocytosis (ET)
• myelofibrosis with myeloid metaplasia (MMM)
• myelodysplastic syndromes (MDS)

c) Lymphocytes

• Lymphopoiesis
• approach to lymphadenopathy
• approach  to splenomegaly
• acute lymphocytic leukemia (ALL)
• chronic lymphocytic leukemia (CLL)
• biology of CLL
• Hodgkin's disease
• non-Hodgkin lymphoma (NHL)
• follicular cell lymphoma (FCL)
• peripheral T-cell lymphoma (PTCL)
• multiple myeloma
• amyloidosis

back to top

Part 5. Bleeding and Clotting

• Approach to abnormal Bleeding
• Platelets in Health and disease
• Thrombocytopenia
• Von Willebrand's disease
• Thrombophilia and venous thromboembolism
• Anti-phospholipid antibody syndrome
• Heparin induced thrombocytopenia (HIT)
• Thrombotic thrombocytopenic purpura (TTP)

back to top

Part 6. Targeted Therapy

• targeted therapy of CML
• antisense oligonucleotides  (anti BCL-2)
• thalidomide and Lenalidomide
• rituximab (anti CD20)
• targeted therapy of AML
• epigenetic therapies
• vascular endothelial growth factor (VEGF)
• Personalized therapy
• Proteins
• Proteomics
• MicroRNAs

back to top

You may freely use The  QxMD Hematology Calculator which has many interesting uses.